Inhibition activity of aluminium oxide nanoparticles for herpes simplex type 1
Several studies have shown that herpes simplex type 1) HSV-1 (is one of the viruses resistant to medications, so potential antiherpetic agents need to be evaluated. This study aimed to evaluate the impact of aluminium oxide Nanoparticles (Al2O3-NPs) on the HSV-1 infection. Characterization of Al2O3-...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Guilan
2023-01-01
|
| Series: | Caspian Journal of Environmental Sciences |
| Subjects: | |
| Online Access: | https://cjes.guilan.ac.ir/article_6203_b7e12e17c449b83245f8118f917a3c84.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Several studies have shown that herpes simplex type 1) HSV-1 (is one of the viruses resistant to medications, so potential antiherpetic agents need to be evaluated. This study aimed to evaluate the impact of aluminium oxide Nanoparticles (Al2O3-NPs) on the HSV-1 infection. Characterization of Al2O3-NPs were performed using field emission scanning electron microscopy (FESEM), X-ray diffraction (XRD), dynamic light scattering (DLS), and high-resolution transmission electron microscopy (HRTEM). The MTT test was used to investigate the toxicity action of Al2O3-NPs on viable cells. Quantitative Real-Time PCR (qRT-PCR) and TCID50 assays were used to achieve antiherpetic performance of Al2O3-NPs. Indirect immunofluorescence assay (IFA) was performed to determine the inhibitory impact of Al2O3-NPs on viral antigen expression, and Acyclovir was utilized as a standard agent in all tests. HSV-1 was subjected to Al2O3-NPs at the maximum non-toxic concentration (100 μg mL-1) led to a decrease of 0.1, 0.7, 1.8, and 2.5 log10 TCID50 in the infectious titer relative to virus control (P < 0.0001). This concentration of Al2O3-NPs was correlated with 16.9%, 47.1 %, 61.2 %, 72.5 % and 74.6 % inhibition rate, calculated on the basis of HSV-1 viral load compared to virus control. Our results have shown that Al2O3-NPs exhibit a robust antiviral activity against HSV-1. This function demonstrates excellent potential for using Al2O3-NP in topical formulations for treating orolabial or genital herpetic lesions. |
|---|---|
| ISSN: | 1735-3033 1735-3866 |